|
|
|
 |
|
 |
Board of Directors
| |
| Ralf Hahn |
| Chairman, Co-founder |
| A share holder and manager of various pharmaceutical companies in Israel and abroad, Ralf Hahn has extensive experience in production and marketing. Mr. Hahn is also President of Tuteur SACIFIA, and a board member of the Argentinean companies Droplata S.A and Tecno-Aire S.A. |
| |
|
| |
| David Tsur |
| CEO & President, Co-founder |
| David Tsur is vastly experienced in business development in the public and private sectors. Prior to co-founding Kamada, Mr. Tsur was CEO of Arad Systems and RAD Chemicals. He has also held various positions in the Israeli Ministry of Industry and Trade, including Chief Economist and Commercial Attaché in Argentina and Iran. Mr. Tsur holds a BA degree in Economics and International Relations and an MBA in Business Management from the Hebrew University of Jerusalem. |
| |
|
| |
| Leon Recanati |
|
| Leon Recanati is currently Chairman and CEO of GlenRock Israel. Previously Mr. Recanati was CEO and/or Chairman of IDB Holding Corporation; Clal Industries and Investments; Discount Investment Corporation; Azorim Investment Development and Construction; Delek Israel Fuel Corporation; and Super-Sol, in addition to holding other positions with a variety of companies. He also initiated Clal Biotechnologies, the largest biotechnology investment company operating in Israel. Mr. Recanati holds an MBA degree from the Hebrew University of Jerusalem and Honorary Doctorates from the Technion Institute of Technology and Tel Aviv University. |
| |
|
| |
| Ziv Kop |
|
| With over a decade of management experience in strategic planning and business development, Ziv Kop is Director of Investment at GlenRock Israel. Prior to joining GlenRock, Mr. Kop was General Manager of POC Management Consulting, a leading Israeli consultancy in the field of strategic planning. Recently, Mr. Kop was ranked among the ten most promising young managers by Israeli business magazine "The Marker.". Mr. Kop is a graduate of Tel Aviv University Law School and Business School (with distinction), and also completed the prestigious, intensive one-month INSEAD Young Managers Program. |
| |
|
| |
| Alicia Rotbard |
|
| Alicia Rotbard is a board member of several public and private companies, represents the public at Clal, Pilat and Nexus, and provides consulting services for high-tech companies. She is the founder and former CEO of Doors Information Systems, and former president and CEO of Quality Computers Ltd. Ms. Rotbard was also Deputy General Manager of the Tel Aviv Stock Exchange, managing its computer department and operations. Ms. Rotbard holds a BSc in Mathematics and Physics from the Hebrew University of Jerusalem. |
| |
|
| |
| Tuvia Shoham |
|
| Tuvia Shoham has extensive experience as a financial consultant for companies in various industry sectors, including managing a wide range of financial arrangements and advising businesses on recovery and privatization plans. Mr. Shoham was previously a partner with the accountancy firm of PricewaterhouseCoopers Israel - Kesselman & Kesselman, and served as Kamada’s accountant for many years. He is a CPA and also holds an MBA degree from the Hebrew University in Jerusalem. |
| |
|
| |
| Doron Lancet, Phd |
|
| Prof. Doron Lancet pioneered genome research in Israel, and currently heads the Crown Human Genome Center at the Weizmann Institute. For 10 years he co-chaired the National Genome Knowledge Center of Israel's Ministry of Science and Technology. In his capacity, he initiated research programs involving discovery of human disease genes, DNA chip research, advanced technologies for exploring genetic variation and next-generation sequencing. Lancet has a B.Sc. in Chemistry from the Hebrew University of Jerusalem, and a Ph.D. in Chemical Immunology from the Weizmann Institute of Science. |
| |
|
| |
|
|
|
|
|
More
|
